Pharmacotherapy Publishing Inc
View my basket
Atypon Link logo

You have no access to this article

Causes and Consequences of Critical Bleeding and Mechanisms of Blood Coagulation


Author(s): Lisa Hall Zimmerman
doi: 10.1592/phco.27.9part2.45S
Prev | Table of contents | Next
 
View PDF article (199 K) View PDF with links (221 K)
Email this link
 What is RSS?
Trouble viewing articles as PDF?
 
  Pharmacotherapy
 
Print ISSN: 0277-0008
Volume: 27 | Issue: 9part2
Cover date: September 2007
Page(s): 45S-56S
 
 
  Key Words
 
critical bleeding, blood coagulation, pharmacy practice.
 
  Abstract

Pharmacists who practice in the critical care setting require a solid background on the causes and consequences of bleeding, as well as the mechanisms of hemostasis. This article provides an overview of these topics. Bleeding and outcomes as a result of surgery and trauma, from medical and pharmacologic causes, and in obstetrics and gynecology are discussed. Patients with brain trauma, those with inherited and acquired bleeding disorders, and patients undergoing therapeutic anticoagulation are addressed, as these are populations at special risk for severe bleeding. Bleeding events as a result of hypothermia, acidosis, and disseminated intravascular coagulation are also discussed, as is the pathophysiology of massive blood loss. Traditional and newer cell-based models of coagulation mechanisms are described and compared. Application of this information in pharmacy practice will help ensure that therapies to manage and arrest blood loss are used appropriately in a wide variety of clinical scenarios.

 
  Author(s) affiliations
 
1Department of Pharmacy Services, Detroit Receiving Hospital-University Health Center, Detroit, Michigan.
*Address reprint requests to Lisa Hall Zimmerman, Pharm.D., BCPS, BCNSP, Detroit Receiving Hospital, University Health Center, 4201 St. Antoine Boulevard, Detroit, MI 48201
 
  This article has been cited by:
1.
 
Pharmacologic Interventions for the Management of Critical Bleeding.
Stacy Voils.
Pharmacotherapy |  27 |  9part2 |  69S-84S
View Header/Abstract | View PDF article (157 KB) | PDF Plus (191 KB) 
2.
 
Key Concepts in the Management of Difficult Hemorrhagic Cases.
Robert MacLaren.
Pharmacotherapy |  27 |  9part2 |  93S-102S
View Header/Abstract | View PDF article (101 KB) | PDF Plus (119 KB)